Taken O
together O
, O
these O
results O
make O
it O
clear O
that O
ATP-bound -
forms O
of O
ORC B-protein-complex
and O
Cdc6p B-protein
are O
likely O
to O
be O
required O
for O
productive O
interactions O
and O
pre-RC B-protein-complex
formation O
. O

Additional O
experiments O
were O
therefore O
performed O
to O
clarify O
whether O
the O
Vps10p B-protein
cd B-protein-domain
could O
in O
fact O
bind O
to O
human O
GGA1 B-protein
and O
GGA2 B-protein
. O

EH B-protein-domain
domains O
from O
Eps15 B-protein
and O
Eps15R B-protein
bind O
to O
NPF-containing -
peptides O

We O
conclude O
that O
the O
Arp1 B-protein
subunit O
of O
dynactin B-protein-complex
binds O
directly O
to O
betaIII B-protein
spectrin I-protein
. O

We O
thus O
used O
recombinant O
NFATp B-protein
and O
Sp1 B-protein
and O
a O
human O
TNF-α B-DNA
promoter I-DNA
fragment O
spanning O
from O
positions O
−200 O
to O
+87 O
relative O
to O
the O
TNF-α B-DNA
transcription I-DNA
start I-DNA
site I-DNA
and O
performed O
quantitative O
DNase B-protein
I I-protein
footprinting O
to O
determine O
the O
precise O
patterns O
of O
binding O
of O
NFATp O
and O
Sp1 O
to O
the O
TNF-α O
promoter O
in O
vitro O
. O

( O
A O
) O
Precursor O
lacking O
the O
first O
82 O
amino O
acid O
residues O
of O
BCS1 B-protein
can O
bind O
to O
OMV B-organelle
in O
a O
receptor-dependent O
manner O
. O

A O
1-kb O
fragment O
of O
PAC B-experimental-construct
clone I-experimental-construct
8856 O
was O
isolated O
by O
PCR B-assay
using O
the O
oligonucleotides O
LF-35 B-chemical
( O
binding O
antisense O
in O
the O
PPARγ2 B-DNA
5′-UTR I-DNA
) O
and O
the O
oligonucleotide O
LF-58 B-chemical
( O
binding O
sense O
at O
position O
-1000 O
of O
the O
PPARγ2) O
, O
was O
sequenced O
, O
and O
was O
inserted O
into O
EcoRV B-protein
site O
of O
pBluescript B-experimental-construct
( O
Stratagene O
, O
La O
Jolla O
, O
CA) O
. O

Concomitant O
with O
increased O
GSK3beta B-protein
activity O
, O
relative O
levels O
of O
KLC O
phosphorylation O
were O
increased O
, O
and O
the O
amount O
of O
kinesin-I B-protein-complex
bound O
to O
MBOs B-organelle
was O
reduced O
. O

Thus O
, O
APP B-protein
might O
have O
a O
similar O
role O
as O
a O
transcytotic O
carrier O
of O
an O
as O
yet O
unidentified O
ligand O
which O
would O
bind O
to O
APP O
on O
the O
presynaptic O
terminal O
and/or O
axonal O
membrane O
. O

We O
show O
that O
BMP7 B-protein
and O
activin B-protein-complex
bind O
to O
the O
same O
type O
II O
receptors O
, O
ActRII B-protein
and O
IIB B-protein
, O
but O
recruit O
distinct O
type O
I O
receptors O
into O
heteromeric O
receptor O
complexes O
. O

This O
is O
in O
agreement O
with O
the O
binding O
affinity O
of O
native O
apoE B-protein
isoforms O
for O
Abeta B-peptide
( O
apoE2 B-protein-isoform
> O
apoE3 B-protein-isoform
> O
apoE4 B-protein-isoform
) O
( O
15 O
, O
41 O
) O
and O
reduced O
LRP-dependent -
uptake O
of O
apoE4/Abeta B-protein-complex
complexes O
in O
CHO B-cell
cells O
( O
38) O
. O

The O
results O
suggest O
unanticipated O
roles O
for O
this O
region O
in O
actin B-protein-family
binding O
to O
myosin B-protein-complex
, O
tropomyosin B-protein-family
, O
and O
possibly O
troponin B-protein-family
. O

C O
, O
disruption O
of O
Ca B-chemical
-dependent O
phospholipid B-chemical
binding O
does O
not O
inhibit O
Ca O
-dependent O
syntaxin B-protein-family
1 I-protein-family
binding O
to O
synaptotagmin B-protein-family
. O

However O
, O
since O
we O
previously O
showed O
that O
SRF B-protein
binding O
to O
each O
of O
the O
CArG B-DNA
boxes I-DNA
is O
mutually O
exclusive O
( O
53) O
, O
it O
is O
likely O
that O
a O
single O
intact O
CArG B-DNA
box I-DNA
is O
also O
sufficient O
to O
support O
bFGF-mediated -
activation O
. O

Binding O
of O
4E-BPs B-protein
to O
eIF4E B-protein-complex
is O
regulated O
by O
ordered O
phosphorylation O
of O
critical O
proline-directed O
Ser/ O
Thr O
residues O
on O
4E-BP1 B-protein
[ O
15 O
, O
16 O
] O
. O

It O
is O
interesting O
to O
note O
that O
deletion O
of O
coding O
exon O
3 O
or O
4 O
did O
not O
significantly O
affect O
PR B-protein-domain
binding O
to O
RIZ B-protein
proteins O
, O
even O
though O
both O
exons O
encode O
conserved O
sequences O
. O

Since O
paralog O
members O
exhibit O
relatively O
conserved O
amino O
acid O
sequences O
, O
these O
data O
make O
it O
likely O
that O
all O
39 O
HOX B-protein-family
proteins O
bind O
CBP B-protein
. O

H2A-H2B B-protein-complex
stabilizes O
binding O
of O
NAP-1 B-protein
to O
p300 B-protein
. O

A O
cadherin B-protein-family
mutant O
unable O
to O
bind O
PS1 B-protein-domain
is O
not O
cleaved O
by O
the O
PS1/gamma-secretase B-protein
activity O
To O
examine O
whether O
PS1 O
binding O
to O
E-cadherin B-protein
is O
necessary O
for O
the O
PS1/gamma-secretase O
cleavage O
, O
we O
used O
E-cadherin B-protein
mutant I-protein
GGG759-761AAA O
( O
Thoreson O
et O
al O
. O
, O
2000) O
. O

Binding O
of O
armadillo B-protein-motif
to O
dTCF B-protein
has O
been O
shown O
to O
reduce O
the O
ability O
of O
CBP B-protein
to O
catalyze O
this O
reaction O
, O
perhaps O
by O
steric O
interference O
[ O
97] O
. O

Clearly O
, O
the O
demonstration O
that O
PS B-protein-family
predominantly O
binds O
mature O
Nct B-protein
additionally O
questions O
the O
existence O
of O
the O
spatial O
paradox O
. O

Within O
the O
nucleus O
, O
phosphorylation O
at O
Ser133 O
might O
affect O
the O
ability O
of O
CREB B-protein
to O
dimerize O
with O
different O
bZIP B-protein-domain
partners O
, O
or O
phosphorylation O
at O
Ser133 O
might O
promote O
CREB O
binding O
to O
the O
CRE B-DNA
. O

In O
Vitro O
Interaction O
and O
Binding O
Affinity O
between O
the O
EPRS B-DNA
and O
IRS B-DNA
Repeats I-DNA

Interaction O
between O
the O
repeated B-protein-motif
motifs I-protein-motif
of I-protein-motif
EPRS I-protein-motif
and O
IRS B-protein-motif
was O
previously O
shown O
by O
genetic O
analysis O
( O
18) O
. O

Therefore O
, O
we O
examined O
the O
binding O
of O
Raf-1 B-protein
to O
Ras B-protein-family
in O
the O
Spry B-cell
cell O
lines O
( O
28) O
. O

Interestingly O
, O
we O
have O
found O
that O
TDP-43 B-protein
can O
efficiently O
bind O
a O
number O
of O
( B-DNA
UG I-DNA
) I-DNA
repeats I-DNA
equal O
to O
or O
greater O
than O
six O
and O
that O
there O
is O
a O
relationship O
between O
the O
number O
of O
( O
UG O
) O
repeats O
and O
the O
efficiency O
of O
binding O
. O

Both O
Gal11p B-protein
and O
TFIIE B-protein
can O
bind O
to O
TFIIH B-protein
, O
pointing O
to O
a O
direct O
effect O
of O
these O
proteins O
on O
TFIIH B-protein
CTD I-protein
kinase I-protein
activity O
[ O
24] O
. O

A O
similar O
C-tail O
release O
is O
induced O
by O
arrestin B-protein-family
binding O
to O
P-Rh* -
( O
16 O
, O
27) O
, O
i O
. O
e O
. O
by O
the O
normal O
process O
of O
wild O
type O
arrestin O
' O
s O
transition O
into O
its O
active O
state O
. O

SMAD-induced -
transcriptional O
stimulation O
is O
inhibited O
by O
an O
E1A B-protein
protein O
that O
binds O
p300/CBP B-protein-family
but O
not O
by O
an O
E1A O
protein O
unable O
to O
bind O
p300/CBP O
in O
two O
different O
cell O
lines O
treated O
with O
TGF-beta B-protein-family
. O

  O
As O
expected O
, O
HP1 B-protein
specifically O
bound O
to O
the O
H3 B-protein-family
tail O
peptide O
methylated O
at O
K9 O
( O
Fig O
. O
5B) O
. O

A O
and O
B O
show O
that O
tropomyosin B-protein-family
was O
bound O
to O
the O
actin B-protein-family
in O
both O
the O
undiluted O
( O
100 O
nM O
actin O
+ O
100 O
nM O
tropomyosin O
) O
and O
the O
10-fold O
diluted O
samples O
, O
respectively O
. O

28 O
With O
Aβ B-peptide
accumulation O
and O
neuronal O
dysfunction O
, O
neuronal O
or O
astrocyte-generated O
apoE B-protein
may O
potentially O
bind O
to O
Aβ O
intraneuronally O
and/or O
extracellularly O
with O
subsequent O
neuronal O
internalization O
, O
explaining O
the O
observation O
of O
apparent O
increased O
apoE O
immunoreactivity O
in O
Aβ42 B-cell
immunoreactive I-cell
neurons I-cell
. O

To O
confirm O
that O
the O
soluble O
ADAM12 B-protein
cytoplasmic O
tails O
bind O
to O
α-actinin-2 -
, O
we O
did O
immunoprecipitation O
experiments O
by O
cotransfecting O
ADAM12 O
cytoplasmic O
tail O
constructs O
and O
α-actinin-2-encoding O
plasmid O
in O
CHO B-cell
cells O
. O

The O
results O
demonstrated O
that O
DmORC1 B-protein
bound O
to O
HP1 B-protein
with O
the O
highest O
recovery O
( O
Figure O
6A) O
. O

The O
effect O
was O
specific O
to O
rapamycin B-drug
, O
as O
FK506 B-chemical
, O
an O
immunosuppressant O
that O
also O
binds O
FKBP12 B-protein
but O
does O
not O
target O
mTOR B-protein
, O
had O
no O
effect O
on O
the O
interaction O
, O
nor O
did O
ethanol B-chemical
, O
the O
vehicle O
used O
for O
both O
drugs O
. O

C O
, O
double-reciprocal O
plot O
for O
the O
adducin-dependent -
binding O
of O
spectrin B-protein-complex
to O
actin B-protein-family
data O
shown O
in O
panels O
A O
and O
B O
. O

A O
cDNA B-experimental-construct
encoding O
the O
ligand-binding O
domain O
of O
the O
EPO B-protein
receptor I-protein
fused O
to O
c-ABL B-protein
was O
generated O
by O
PCR B-assay
using O
the O
cDNAs O
for O
the O
murine O
EPO O
receptor O
and O
murine O
c-ABL O
as O
templates O
( O
21 O
, O
22) O
. O

HTH B-protein-motif
binds O
EXD B-protein
directly O
via O
the O
MH B-protein-domain
domain I-protein-domain

( B-DNA
CT)n I-DNA
regions I-DNA
are O
known O
to O
bind O
GAGA B-protein
factor O
, O
a O
dominant O
enhancer O
of O
PEV B-process
thought O
to O
play O
a O
role O
in O
generating O
an O
accessible O
chromatin O
structure O
. O

To O
further O
define O
the O
interaction O
domain O
for O
RhoA B-protein
binding O
to O
Kv1 B-protein
. I-protein
2 I-protein
, O
we O
constructed O
a O
deletion O
mutant O
of O
Kv1 O
. O
2 O
( O
Kv1 B-protein
. I-protein
2-deltaN125 I-protein
) O
in O
which O
the O
distal O
125 O
amino O
acids O
of O
the O
amino O
terminus O
were O
removed O
. O

The O
intracellular O
concentration O
of O
Ubc2 B-protein
is O
consistently O
within O
the O
micromolar O
range O
, O
which O
is O
saturating O
with O
respect O
to O
the O
Km O
of O
102 O
± O
13 O
nM O
for O
uncharged O
HsUbc2b B-protein
binding O
to O
E1 B-protein-family
and O
theKm O
of O
54 O
± O
18 O
nM O
for O
HsUbc2b-ubiquitin B-protein-complex
thiolester I-protein-complex
binding O
to O
E3α B-protein
. O

( O
D O
) O
Binding O
of O
Tsg101 B-protein
to O
Hrs B-protein
deletion O
mutants O
. O

  O
In O
contrast O
, O
CC2 B-protein-domain
, O
p115 B-protein
CT O
( O
COOH-terminal O
75 O
aa O
of O
p115 O
, O
which O
binds O
to O
Giantin B-protein
and O
GM130 B-protein
) O
and O
GM130 B-protein
NT I-protein
( O
NH2-terminal O
73 O
aa O
of O
GM130 O
, O
which O
binds O
p115 O
) O
had O
no O
effect O
( O
Fig O
. O
2 O
, O
E O
and O
F) O
. O

  O
Note O
that O
unfused O
GST B-experiment-tag
binds O
the O
affinity O
matrix O
more O
efficiently O
, O
resulting O
in O
very O
strong O
GST O
monomer O
and O
dimer O
bands O
. O

Radiolabeled O
in O
vitro O
- O
translated O
GSK3 B-protein
and O
CK1epsilon B-protein
bind O
Tcf3 B-reagent
beads I-reagent
. O

  O
GST-fusion -
protein O
or O
GST O
( O
5 O
mug O
each O
) O
were O
bound O
to O
GT-agarose B-reagent
beads I-reagent
and O
incubated O
with O
32P-labeled B-experiment-tag
v-Fms B-protein
, O
c-Fms B-protein
, O
and O
vc-Fms B-experimental-construct
. O

  O
TFIIA B-protein
binding O
to O
TBP B-protein
can O
prevent O
the O
inhibitory O
effects O
of O
transcriptional O
repressors O
, O
Dr1/DRAP1 -
, O
HMG1 B-protein
, O
DSP1 B-protein
, O
MOT1 B-protein
, O
and O
TAFII250 B-protein
( O
8-14) O
. O

  O
A O
phosphoprotein O
of O
62-64 O
kDa O
was O
clearly O
seen O
in O
association O
with O
RasGAP B-protein
upon O
ephrin-B1 B-protein
stimulation O
, O
demonstrating O
that O
RasGAP O
not O
only O
binds O
to O
EphB2 B-protein
, O
but O
also O
interacts O
with O
other O
proteins O
in O
ephrin-B1-stimulated O
cells O
. O

Cdc6p B-protein
increases O
the O
sequence-specific O
binding O
of O
ORC B-protein-complex
to O
origin O
DNA B-DNA
. O

ICAM-3 B-protein
bead O
binding O
to O
THP-1 B-cell
cells O
was O
uniformly O
less O
than O
5% O
in O
repeat O
experiments O
. O

  O
Specifically O
, O
we O
have O
determined O
that O
CD44s B-protein
binds O
to O
c-Src B-protein
kinase O
both O
in O
vivo O
( O
Figs O
. O
1 O
, O
6 O
, O
8 O
, O
and O
9 O
) O
and O
in O
vitro O
( O
Fig O
. O
2) O
. O

Displayed O
are O
the O
consensus O
DNA B-DNA
sequences O
for O
the O
EGR-1 B-protein
and O
Sp1 B-protein
binding O
sites O
and O
the O
13 O
bp O
overlapping O
EGR-1 O
and O
Sp1 O
binding O
sites O
of O
GC-box B-DNA
2 I-DNA
. O

  O
The O
mutation O
in O
the O
APPKPPR B-protein-region
sequence I-protein-region
( O
mPR B-protein-region
) O
abolished O
the O
binding O
of O
CIZ B-protein
to O
Cas B-protein-family
SH3 B-protein-domain
( O
Fig O
. O
3B O
, O
lanes O
1 O
, O
2) O
, O
strongly O
suggesting O
that O
this O
sequence O
was O
the O
binding O
site O
for O
Cas O
SH3 O
. O

As O
expected O
, O
the O
affinity O
of O
[ B-drug
3H]LY341495 I-drug
in O
rat O
brain O
shown O
here O
is O
much O
higher O
than O
that O
observed O
for O
group B-protein-family
II I-protein-family
binding O
with O
[ B-chemical
3H]glutamate I-chemical
( O
Kd= O
187 O
nM) O
. O

  O
Moreover O
, O
concentrations O
of O
tamoxifen B-drug
as O
low O
as O
0 O
. O
25 O
muM O
substantially O
increased O
the O
binding O
of O
calmodulin B-protein
to O
the O
estrogen B-protein-family
receptor I-protein-family
. O

  O
Moreover O
, O
we O
showed O
that O
the O
binding O
regions O
of O
ponsin B-protein
and O
vinculin B-protein
were O
the O
region O
containing O
the O
first O
and O
second O
SH3 B-protein-domain
domains O
and O
the O
proline-rich O
region O
, O
respectively O
. O

  O
( O
Table O
II) O
, O
suggesting O
that O
the O
inhibitory O
role O
of O
intracellular O
Na+ B-chemical
is O
not O
mediated O
by O
directly O
affecting O
the O
binding O
of O
Nedd4 B-protein-family
to O
ENaC B-protein-family
. O

( O
B O
) O
The O
Gal4 B-protein
AD B-protein-domain
binds O
Sug1/Rpt6 B-protein
and O
Sug2/Rpt4 B-protein
directly O
. O

Our O
results O
suggest O
a O
mechanism O
by O
which O
DM B-protein
binding O
to O
MHC B-protein-family
class I-protein-family
II I-protein-family
molecules O
translates O
into O
peptide O
release O
via O
disturbance O
of O
key O
interactions O
between O
the O
peptide O
and O
MHC O
class O
II O
molecule O
near O
the O
P1 B-protein-region
pocket I-protein-region
. O

Functional O
consequences O
of O
phosphorylation O
reported O
here O
include O
modulation O
of O
adducin B-protein-family
interactions O
with O
spectrin B-protein-family
and O
actin B-protein-family
by O
PKA B-protein-complex
and O
inhibition O
of O
calmodulin B-protein
binding O
by O
PKA O
and O
PKC B-protein-family
. O

  O
To O
ascertain O
that O
serum B-protein-family
antibodies I-protein-family
actually O
bound O
to O
TBP B-protein
, O
and O
not O
to O
its O
fusion O
partner O
GST B-experiment-tag
, O
the O
sera O
were O
tested O
in O
control O
wells O
coated O
with O
GST O
in O
PBS B-reagent
at O
a O
concentration O
of O
1 O
mug/ml O
. O

  O
It O
has O
been O
suggested O
that O
GSK-3beta B-protein
binding O
to O
Axin B-protein
affects O
the O
Axin O
conformation O
, O
resulting O
in O
a O
block O
in O
MEKK B-protein
binding O
( O
36) O
. O

  O
To O
overcome O
this O
, O
we O
developed O
a O
novel O
approach O
for O
the O
labeling O
and O
detection O
of O
GST B-experiment-tag
fusion O
proteins O
on O
membranes O
based O
on O
the O
specific O
and O
rapid O
binding O
of O
glutathione B-chemical
to O
GST O
. O

It O
has O
been O
suggested O
( O
33 O
) O
that O
in O
Db B-protein
this O
pocket O
could O
just O
as O
well O
bind O
Ser O
or O
an O
amino O
acid O
with O
a O
longer O
side O
chain O
and O
that O
this O
is O
why O
peptides O
binding O
to O
Db O
do O
not O
show O
a O
stringent O
requirement O
for O
Ser O
at O
P2 B-protein-domain
. O

Physiologically O
, O
iron B-chemical
delivery O
to O
cells O
is O
mediated O
by O
the O
iron O
carrier O
transferrin B-protein-family
( O
Tf) -
, O
which O
initially O
binds O
to O
a O
specific O
cell O
surface O
receptor O
, O
undergoes O
endocytosis O
and O
, O
at O
the O
end O
of O
a O
short O
permanence O
in O
the O
cell O
, O
it O
is O
finally O
exocytosed O
[ O
21] O
. O

The O
data O
provided O
here O
suggest O
that O
EBNA1 B-protein-complex
binding O
to O
the O
DS B-DNA
element I-DNA
might O
be O
required O
to O
direct O
hsORC B-protein-complex
to O
the O
EBV B-cell
genome O
. O

  O
Although O
the O
calmodulin B-protein
binding O
domain O
of O
the O
estrogen B-protein
receptor I-protein
has O
not O
been O
identified O
, O
these O
apparently O
discrepant O
data O
can O
be O
interpreted O
in O
the O
context O
of O
recently O
solved O
crystal O
structures O
( O
38) O
. O

This O
effect O
was O
dose-dependent O
in O
that O
increasing O
concentrations O
of O
Slit B-protein-family
led O
to O
more O
binding O
of O
srGAP1 B-protein
with O
Robo1 B-protein
( O
Figure O
4D) O
. O

  O
Interestingly O
, O
it O
has O
been O
described O
that O
GSK-3 B-protein-complex
can O
bind O
E-cadherin B-protein-family
to O
phosphorylate O
it O
, O
which O
would O
result O
in O
a O
tighter O
interaction O
with O
- O
catenin B-protein-family
[ O
20] O
. O

It O
has O
been O
found O
that O
KSR B-protein
is O
bound O
directly O
to O
MEK B-protein
in O
the O
cytoplasm O
of O
quiescent O
cells O
; O
upon O
activation O
of O
the O
MAPK B-protein-family
pathway O
by O
growth O
factors O
or O
activated O
RAS B-protein-family
, O
KSR O
is O
relocalized O
to O
the O
plasma O
membrane O
in O
a O
complex O
containing O
RAF B-protein
, O
MEK O
, O
and O
MAPK O
( O
Michaudet O
al O
. O
1997 O
; O
Denouel-Galyet O
al O
. O
1998 O
; O
Yuet O
al O
. O
1998 O
; O
Stewartet O
al O
. O
1999) O
. O

  O
In O
sum O
, O
the O
binding O
of O
talin B-protein
to O
integrin B-protein-family
beta I-protein-family
cytoplasmic O
domains O
is O
crucial O
for O
integrin O
function O
and O
is O
involved O
in O
the O
regulation O
of O
integrin O
activation O
and O
clustering O
. O

Sema3A B-protein
binding O
to O
NP-1/Plex -
1 -
- O
expressing O
COS-7 B-cell
cells O
is O
indistinguishable O
from O
NP-1-expressing O
COS-7 O
cells O
at O
saturating O
concentrations O
of O
ligand O
( O
3 O
nM) O
. O

These O
results O
indicate O
that O
the O
ChIP B-assay
and O
DamID B-assay
assays O
both O
accurately O
reflect O
bona O
fide O
GAF B-protein-domain
binding O
sites O
in O
vivo O
. O

K O
d O
for O
TNP-ATP -
binding O
to O
MBP_6 B-protein
. I-protein
2CΔ36 I-protein
at O
pH O
7 O
. O
5 O
and O
6 O
. O
5 O
calculated O
using O
Equation O
1 O
for O
the O
F O
obsdata O
in O
Fig O
. O
10 O
A O
were O
, O
at O
pH O
7 O
. O
5 O
, O
K O
d O
= O
6 O
. O
8 O
± O
0 O
. O
6 O
μM O
, O
N O
o O
= O
0 O
. O
51 O
± O
0 O
. O
02 O
mol O
of O
TNP-ATP/mol O
of O
protein O
and O
, O
at O
pH O
6 O
. O
5 O
, O
K O
d O
= O
1 O
. O
4 O
± O
0 O
. O
1 O
μM O
. O

A O
shows O
the O
amino O
acid O
comparison O
of O
the O
three O
FK506 B-drug
binding O
domains O
of O
dFKBP59 B-protein
with O
human O
FKBP12 B-protein
and O
FKBP12 B-protein
. I-protein
6 I-protein
. O

Inhibition O
of O
Actin O
Binding O
by O
PhosphorylationWe O
examined O
the O
effects O
of O
phosphorylation O
on O
fascin-actin -
binding O
and O
found O
that O
phosphorylation O
by O
PKC B-protein-complex
inhibits O
actin O
binding O
of O
fascin O
. O

This O
experiment O
showed O
that O
Bcr B-protein
increased O
the O
binding O
of O
AF-6 B-protein
to O
activated O
Ras B-protein-family
in O
a O
reaction O
that O
requires O
binding O
of O
its O
C O
terminus O
to O
the O
PDZ B-protein-domain
domain O
of O
AF-6 O
. O

  O
Thus O
, O
a O
straightforward O
interpretation O
of O
our O
results O
might O
be O
that O
overexpression O
of O
the O
GTP-bound B-protein
form I-protein
of I-protein
Rab3a I-protein
inhibits O
Ca2+-induced -
exocytosis O
by O
sequestering O
Ca2+/CaM -
. O

  O
Therefore O
, O
it O
is O
possible O
that O
the O
amino-terminal O
and O
SH3 B-protein-domain
domains O
of O
Abi-1 B-protein
can O
bind O
simultaneously O
to O
Sos B-protein-family
or O
Grb2 B-protein
and O
Abl B-protein
, O
respectively O
. O

We O
studied O
the O
fMLP-induced -
activation O
of O
p38 B-protein-family
and O
p44/p42 B-protein-family
in O
differentiated O
HL-60 B-cell
cells O
using O
phosphospecific B-reagent
antibodies I-reagent
that O
bind O
only O
the O
activated O
form O
of O
p38 O
or O
p44/p42 O
. O

It O
is O
intriguing O
that O
our O
observation O
that O
APP B-protein
directly O
binds O
to O
the O
TPR B-protein-domain
domain O
of O
KLC B-protein
and O
that O
APP O
binding O
to O
KLC O
is O
inhibited O
by O
the O
KLC-All B-reagent
antibody I-reagent
, O
which O
binds O
specifically O
to O
the O
TPR O
domain O
of O
KLC O
( O
Stenoien O
and O
Brady O
1997 O
) O
, O
is O
similar O
to O
recent O
work O
on O
the O
SYD B-protein
protein O
. O

  O
Based O
on O
these O
observations O
, O
we O
speculated O
that O
the O
C-term O
might O
function O
as O
an O
autoinhibitory O
domain O
, O
and O
that O
binding O
of O
tRNA B-RNA
to O
the O
HisRS B-protein
region O
would O
overcome O
this O
inhibition O
. O

  O
These O
Tcf-binding B-protein-family
proteins I-protein-family
appear O
to O
suppress O
the O
complex O
formation O
of O
beta-catenin B-protein-family
, O
Tcf O
, O
and O
DNA B-DNA
. O
Pontin52 B-protein
is O
a O
nuclear O
protein O
that O
binds O
to O
beta-catenin O
, O
but O
the O
physiological O
significance O
is O
not O
known O
( O
33) O
. O

  O
The O
general O
transcription O
factors O
TFIIA B-protein
and O
TFIIB B-protein
bind O
directly O
to O
TBP B-protein
, O
stabilize O
its O
association O
with O
the O
promoter B-DNA
, O
and O
form O
the O
core O
of O
the O
RNA B-protein-complex
polymerase I-protein-complex
II I-protein-complex
preinitiation I-protein-complex
complex I-protein-complex
( O
18 O
, O
36 O
, O
48) O
. O

  O
However O
, O
the O
molecular O
mechanism O
by O
which O
PPARs B-protein-family
interfere O
with O
NF-kappaB B-protein-complex
binding O
to O
the O
TNF-alpha B-DNA
promoter I-DNA
is O
unknown O
. O

  O
( O
vii O
) O
Overexpression O
of O
a O
Grb10 B-protein
mutant O
lacking O
the O
SH2 B-protein-domain
domain O
impairs O
IGF-I-mediated -
ubiquitination O
of O
the O
IGF-IR B-protein
in O
both O
p6 B-cell
and O
p6/Grb10 B-cell
cells O
, O
suggesting O
that O
binding O
between O
Grb10 O
and O
Nedd4 B-protein
is O
critical O
for O
ubiquitination O
of O
the O
receptor O
. O

  O
B O
, O
the O
COOH O
terminus O
of O
p65 B-protein
is O
required O
for O
binding O
of O
TBP B-protein
and O
TFIIB B-protein
. O

  O
Phosphorylation O
of O
CREB B-protein
at O
Ser142 O
has O
been O
shown O
in O
vitro O
to O
disrupt O
the O
binding O
of O
CREB O
to O
the O
KIX B-protein-domain
domain O
of O
CBP B-protein
( O
Parker O
et O
al O
. O
, O
1998 O
; O
Kornhauser O
et O
al O
. O
, O
2002 O
) O
. O

  O
2 O
This O
raised O
the O
possibility O
that O
, O
as O
is O
the O
case O
with O
the O
other O
well O
characterized O
class B-protein-family
B I-protein-family
scavenger I-protein-family
receptor I-protein-family
SR-BI B-protein-family
, O
HDL B-chemical
might O
bind O
directly O
to O
CD36 B-protein
. O

Likewise O
, O
we O
found O
no O
change O
in O
the O
distance O
between O
Cys O
and O
Cys O
of O
RLC B-protein
when O
the O
myosin B-protein-complex
was O
bound O
to O
actin B-protein
. O

Efficient O
binding O
of O
DDP1 B-protein
to O
the O
dodeca-satellite B-DNA
C I-DNA
strand I-DNA
depends O
strongly O
on O
the O
length O
and O
lack O
of O
secondary O
structure O
of O
the O
DNA B-DNA
fragments O
. O

It O
is O
well O
known O
that O
one O
of O
the O
important O
downstream O
effectors O
of O
PKA B-protein-complex
is O
cAMP B-protein
response I-protein
element I-protein
binding I-protein
( O
CREB B-protein
) O
protein O
. O

Instead O
, O
we O
find O
that O
nNOS B-protein-isoform
binds O
to O
the O
second O
PDZ B-protein-motif
repeat I-protein-motif
of O
PSD-95 B-protein
, O
and O
a O
related O
protein O
PSD-93 B-protein
. O

The O
reverse B-protein-family
transcriptase I-protein-family
binds O
to O
the O
epsilon O
stem-loop O
structure O
near O
the O
5′ O
end O
of O
its O
own O
mRNA B-RNA
to O
facilitate O
packaging O
into O
nucleocapsids B-organelle
and O
initiation O
of O
reverse O
transcription O
by O
a O
protein-priming O
mechanism O
, O
utilizing O
a O
tyrosine B-amino-acid
located O
near O
the O
amino O
terminus O
of O
the O
reverse O
transcriptase O
itself O
. O

Various O
quantities O
of O
GST-syntaxin-1a -
were O
incubated O
with O
tomosyn B-protein
( O
10 O
pmol O
) O
on O
nitrocellulose B-reagent
membranes I-reagent
for O
2 O
hr O
. O
Syntaxin-1a O
bound O
to O
tomosyn O
was O
detected O
. O

These O
findings O
are O
consistent O
with O
the O
results O
in O
CAT B-assay
assay O
( O
Fig O
5 O
, O
a O
- O
f O
) O
and O
support O
the O
idea O
that O
the O
nuclear O
translocation O
of O
QM/Jif-1 B-protein
is O
promoted O
by O
normal O
PS1 B-protein
thereby O
inhibiting O
the O
binding O
of O
c-Jun B-protein-complex
homodimer I-protein-complex
to O
TRE B-DNA
. O

For O
example O
, O
Ubc9 B-protein
binds O
the O
basic O
region O
of O
the O
bipartite O
NLS B-protein-motif
of O
the O
androgen B-protein
receptor I-protein
( O
38) O
. O

NC2 B-protein
binds O
to O
TBP B-protein
and O
inhibits O
its O
function O
( O
Goppelt O
and O
Meisterernst O
, O
1996 O
; O
Goppelt O
et O
al O
. O
, O
1996 O
) O
. O

Next O
we O
investigated O
the O
nucleotide O
specificity O
and O
effect O
of O
Mg2+ B-chemical
on O
ATP B-chemical
binding O
to O
synapsins B-protein-family
. O

The O
activity O
of O
PLCdelta1 B-protein
is O
negatively O
regulated O
by O
interaction O
with O
TG B-protein
, O
but O
PLCdelta1 O
is O
released O
from O
this O
inhibitory O
association O
when O
GTP B-chemical
binds O
to O
TG O
. O

To O
examine O
the O
possibility O
, O
293T B-cell
cells I-cell
were O
cotransfected O
with O
vectors O
encoding O
Abl B-protein
, O
SrcKD B-protein
, O
and O
GST-tagged -
Cbl B-protein
. O

GST-Cbl -
was O
precipitated O
, O
and O
the O
binding O
of O
Src B-protein
and O
Abl B-protein
was O
analyzed O
by O
Western O
blotting O
using O
anti-Src B-reagent
and O
anti-Abl B-reagent
antibodies I-reagent
( O
Fig O
. O
​44A) O
. O

These O
investigators O
propose O
that O
HTH B-protein-motif
binding O
to O
EXD B-protein
may O
induce O
a O
conformational O
change O
in O
EXD O
that O
alters O
the O
nuclear O
export/import O
balance O
by O
inactivating O
the O
NES B-protein-motif
, O
thus O
favoring O
nuclear O
import O
. O

To O
further O
explore O
the O
role O
of O
the O
C-terminal O
domain O
in O
the O
heparin B-chemical
binding O
of O
apoE B-protein
, O
we O
used O
apoE O
( O
1-260) O
, O
a O
C-terminal O
truncated O
variant O
that O
is O
monomeric O
rather O
than O
tetrameric O
in O
aqueous O
solution O
( O
21) O
. O

Direct O
SH2-mediated -
binding O
of O
Shc B-protein
to O
FAK B-protein
occurs O
after O
FN B-protein
stimulation O
( O
Schlaepfer O
and O
Hunter O
, O
1997 O
) O
and O
FAK O
can O
directly O
phosphorylate O
Shc O
at O
Tyr317 B-amino-acid
to O
promote O
Grb2 B-protein
binding O
and O
signaling O
to O
ERK2 B-protein
( O
Schlaepfer O
et O
al O
. O
, O
1998 O
) O
. O

To O
investigate O
this O
, O
we O
isolated O
the O
F-actin -
binding O
part O
of O
human O
plasma O
gelsolin B-protein
comprising O
segment O
2 O
and O
3 O
( O
S2–3 O
) O
and O
performed O
competition O
experiments O
under O
conditions O
( O
pH O
6 O
. O
8 O
) O
where O
cofilin B-protein
is O
known O
to O
efficiently O
bind O
to O
F-actin O
and O
only O
causes O
limited O
depolymerization O
( O
14) O
. O

The O
results O
, O
shown O
in O
Fig O
. O
2 O
, O
clearly O
demonstrate O
that O
Gal4 B-protein
binds O
to O
the O
GC-rich B-DNA
region I-DNA
of O
the O
GAL1-10 B-DNA
locus I-DNA
to O
a O
similar O
level O
in O
both O
the O
wild-type O
and O
the O
htz1delta B-cell
strains O
. O

Hsc70 B-protein
Binding O
to O
Clathrin B-protein
Cages O

Thus O
, O
is O
it O
that O
the O
Igs B-protein-family
bind O
to O
an O
autoantigen(s O
) O
on O
specific O
neurons O
that O
‘subsequently O
’ O
show O
signs O
of O
degeneration O
, O
to O
eventually O
express O
caspase B-protein
3 I-protein
and O
die O
, O
due O
to O
the O
Ig B-protein-family
binding O
( O
the O
AD B-disease
autoimmune O
hypothesis) O
, O
or O
alternatively O
, O
do O
the O
dying O
neurons O
express O
a O
‘stress O
’ O
protein(s O
) O
that O
the O
Igs O
inconsequentially O
bind O
( O
alternative O
Ig O
explanation) O
? O

In O
the O
absence O
of O
Wnt B-protein-family
signals O
, O
LEF1 B-protein
binds O
to O
transcriptional O
co-repressors O
TLE B-protein-family
, O
CtBP B-protein
, O
and O
HDACs B-protein-family
to O
inhibit O
gene O
expression O
( O
22) O
. O

dTCF/Pangolin -
is O
the O
cofactor O
necessary O
for O
Armadillo-dependent -
transcriptional O
activitation O
, O
and O
a O
dominant-negative B-protein
form I-protein
of I-protein
dTCF I-protein
that O
no O
longer O
binds O
Armadillo O
inhibits O
the O
ability O
of O
Armadillo O
to O
activate O
transcription O
36 O
, O
37 O
. O

These O
effects O
correlated O
directly O
with O
the O
L501P-sensitive O
direct O
binding O
of O
GR B-protein
to O
the O
homeodomains O
of O
several O
homeodomain O
proteins O
in O
vitro O
and O
in O
transfected O
cells O
and O
were O
rescued O
by O
the O
coexpression O
of O
Oct-2HD B-protein-domain
in O
embryos O
. O

This O
sequence O
shows O
marked O
homology O
to O
the O
amino-terminal O
sequence O
determined O
here O
for O
processed O
Smac/ B-protein
DIABLO I-protein
bound O
to O
XIAP B-protein
, O
AVPIAQ B-protein-region
; O
Smac/ O
DIABLO O
has O
been O
processed O
here O
to O
remove O
the O
first O
55 O
amino O
acids O
. O

As O
shown O
in O
Figure O
6A O
, O
addition O
of O
poly-l-proline B-peptide
, O
even O
in O
large O
excess O
, O
had O
no O
significant O
effect O
on O
the O
binding O
of O
profilin B-protein-family
to O
gephyrin B-protein
, O
although O
in O
corresponding O
ELISAs B-assay
we O
could O
demonstrate O
the O
successful O
masking O
of O
the O
polyproline B-peptide
binding O
site O
on O
profilin O
by O
poly-l-proline O
incubation O
( O
data O
not O
shown) O
. O

At O
early O
time O
points O
after O
activation O
, O
newly O
synthesized O
cyclin B-protein-family
A I-protein-family
is O
also O
quantitatively O
bound O
to O
cdk2 B-protein
( O
see O
8 O
and O
12 O
h O
after O
activation O
of O
Myc) -
; O
taken O
together O
, O
both O
observations O
suggest O
that O
there O
is O
not O
enough O
p130 B-protein
in O
these O
cells O
to O
inhibit O
quantitatively O
newly O
formed O
cyclin B-protein-complex
A-cdk2 I-protein-complex
complexes O
. O

Because O
CtBP B-protein
binds O
to O
the O
MLL B-protein-domain
repression I-protein-domain
domain I-protein-domain
, O
we O
wished O
to O
determine O
whether O
HPC2 B-protein
also O
binds O
to O
the O
MLL O
repression O
domain O
. O

In O
this O
study O
, O
we O
found O
that O
binding O
of O
pp90RSK B-protein
to O
CBP B-protein
did O
not O
preclude O
binding O
of O
phospho-CREB B-protein
to O
CBP O
, O
indicating O
that O
pp90RSK O
may O
interfere O
instead O
with O
recruitment O
of O
a O
general O
transcription O
factor O
to O
CBP O
. O

A O
similar O
mechanism O
involving O
heparin B-chemical
sulfate I-chemical
facilitation O
of O
fibroblast B-protein-family
growth I-protein-family
factor I-protein-family
binding O
to O
FGFR2 B-protein
has O
been O
postulated O
( O
31) O
, O
but O
a O
more O
complex O
role O
in O
inducing O
conformational O
changes O
in O
the O
FGFR2 O
complex O
has O
become O
apparent O
with O
crystallographic O
analysis O
( O
32) O
. O

Chromatin O
immunoprecipitation O
experiments O
confirm O
that O
NFAT5 B-protein
binds O
to O
the O
TNF B-DNA
promoter I-DNA
in O
vivo O
. O

We O
determined O
the O
binding O
affinities O
of O
emerin B-protein
for O
GCL B-protein
, O
BAF B-protein
, O
and O
lamin B-protein
A I-protein
and O
analyzed O
their O
oligomeric O
interactions O
. O

The O
anti-FGF B-reagent
Ab I-reagent
showed O
that O
FGF-2 B-protein
was O
bound O
to O
a O
similar O
extent O
to O
CD44v3-v10 B-protein-isoform
and O
CD44vRA B-protein-isoform
, O
whereas O
CD44s B-protein
did O
not O
bind O
FGF-2 O
. O

Such O
ATP-dependent -
binding O
of O
Hsc70 B-protein
to O
auxilin B-protein
is O
consistent O
with O
previously O
published O
work O
utilizing O
other O
assay O
systems O
( O
Holstein O
et O
al O
. O
, O
1996 O
; O
Jiang O
et O
al O
. O
, O
1997 O
) O
. O

GST B-experiment-tag
beads O
bound O
to O
a O
fusion O
protein O
between O
GST O
and O
TIF2 B-protein
. I-protein
1 I-protein
or O
to O
GST O
alone O
were O
incubated O
with O
in O
vitro O
translated O
wild-type O
or O
mutant O
ERs B-protein-family
in O
the O
presence O
of O
vehicle O
, O
estradiol B-chemical
, O
or O
antiestrogens B-drug
( O
100 O
nM O
) O
overnight O
at O
4 O
degrees O
C O
. O

The O
binding O
of O
GSK3 B-protein-family
to O
Axin B-protein-family
is O
essential O
for O
the O
ability O
of O
Axin O
to O
ventralize O
Xenopus O
embryos O
( O
23) O
. O

Because O
the O
Kd O
value O
for O
E1 B-protein-family
binding O
with O
ubiquitin B-protein-family
is O
in O
the O
submicromolar O
range O
, O
E1-mediated O
ubiquitination O
reactions O
would O
be O
expected O
to O
be O
nearly O
saturated O
by O
10 O
muM O
ubiquitin O
( O
Haas O
and O
Siepmann O
, O
1997 O
) O
. O

For O
example O
, O
a O
high-affinity O
form O
of O
eIF4E B-protein
( O
bound O
to O
eIF4G B-protein
) O
may O
promote O
initial O
40S B-protein-RNA-complex
interactions O
with O
capped O
mRNA B-RNA
but O
subsequently O
convert O
to O
the O
low-affinity O
form O
after O
a O
rearrangement O
of O
the O
preinitiation B-protein-complex
complex I-protein-complex
( O
Fig O
. O
8 O
) O
( O
449) O
. O

Previous O
biochemical O
studies O
on O
the O
binding O
of O
PC B-chemical
and O
PI B-chemical
to O
PI-TP B-protein-family
provided O
evidence O
for O
the O
presence O
of O
separate O
binding O
sites O
for O
the O
phosphorylinositol B-chemical
and O
phosphorylcholine B-chemical
head O
group O
[ O
3 O
. O

The O
binding O
of O
4 B-protein-domain
. I-protein-domain
1G-CTD I-protein-domain
to O
FKBP13 B-protein
but O
not O
to O
FKBP12 B-protein
underscores O
the O
selective O
nature O
of O
immunophilin B-protein-family
interactions O
in O
vivo O
. O

These O
results O
suggest O
that O
the O
binding O
of O
PBX B-protein-family
and O
HOX B-protein-family
to O
PPE B-DNA
is O
crucial O
for O
mouse O
renin B-gene
gene O
expression O
. O

Previous O
studies O
have O
demonstrated O
that O
both O
antibodies O
and O
peptides O
directed O
at O
this O
site O
interfere O
with O
nidogen B-protein-family
binding O
to O
laminin B-protein-family
( O
Mayer O
et O
al O
. O
, O
1993a O
) O
. O

In O
addition O
, O
Sp4 B-protein
also O
prefers O
binding O
to O
a O
GC-box B-DNA
, O
which O
is O
similar O
to O
both O
Sp1 B-protein
and O
Sp3 B-protein
, O
but O
not O
Sp2 B-protein
( O
29) O
. O

We O
found O
that O
amino- O
and O
carboxyl-terminal O
truncated B-protein
forms I-protein
of I-protein
TTP I-protein
, O
as O
well O
as O
a O
77 O
amino O
acid O
fragment O
that O
contained O
both O
zinc O
fingers O
, O
could O
bind O
to O
the O
TNFalpha B-RNA
ARE I-RNA
in O
cell-free O
cross-linking O
and O
gel O
shift O
assays O
. O

However O
, O
it O
has O
recently O
been O
reported O
that O
the O
tumor O
suppressor O
APC B-protein
( O
adenomatous B-protein
polyposis I-protein
coli I-protein
protein I-protein
) O
is O
able O
to O
bind O
to O
the O
RGS B-protein-domain
domain I-protein-domain
of O
axin B-protein
( O
1 O
, O
11 O
, O
25) O
, O
suggesting O
that O
the O
binding O
of O
APC O
to O
this O
region O
may O
be O
important O
for O
normal O
axis O
formation O
. O

Deletion O
of O
the O
UIM B-protein-motif
sharply O
reduced O
the O
efficiency O
with O
which O
Hrs B-protein
bound O
ubiquitin B-protein-family
( O
Fig O
. O
1 O
E) O
. O

Specific O
binding O
of O
calmodulin B-protein-family
to O
NE-dlg/ B-protein
SAP102 I-protein
. O

Nir2 B-protein
was O
also O
shown O
to O
preferentially O
bind O
the O
inactive O
GDP-bound B-protein
form I-protein
of I-protein
RhoA I-protein
( O
Fig O
. O
6A) O
. O

If O
the O
binding O
of O
GBP B-protein
to O
endogenous O
Xgsk-3 B-protein
inhibits O
the O
function O
of O
Xgsk-3 O
, O
leading O
to O
the O
formation O
of O
an O
ectopic O
axis O
, O
it O
should O
be O
possible O
to O
overcome O
the O
effects O
of O
GBP O
by O
ectopically O
expressing O
additional O
Xgsk-3 O
. O

Inhibition O
of O
cell O
adhesion O
induced O
by O
soluble O
galectin-8 B-protein
is O
further O
complicated O
in O
view O
of O
the O
fact O
that O
galectin-8 O
can O
also O
bind O
soluble O
fibronectin B-protein
present O
in O
the O
serum O
. O

The O
hyperphosphorylation O
of O
Cla4 B-protein
can O
be O
induced O
experimentally O
by O
expression O
of O
Clb2 B-protein
and O
the O
GTP-bound -
form O
of O
Cdc42 B-protein
( O
44) O
. O

We O
also O
present O
evidence O
that O
TIM B-protein
alone O
cannot O
repress O
dCLK-CYC-mediated -
transcription O
of O
an O
E-box B-DNA
reporter I-DNA
in O
S2 B-cell
cells I-cell
, O
despite O
a O
report O
that O
TIM O
disrupts O
the O
DNA-binding -
ability O
of O
dCLK O
and O
CYC O
in O
vitro O
( O
Lee O
et O
al O
. O
, O
1999 O
) O
. O

However O
, O
the O
increased O
p53 B-protein
binding O
to O
sds-DNA B-DNA
may O
occur O
, O
but O
apoptosis O
as O
its O
consequence O
may O
be O
blocked O
by O
the O
repair O
protein O
defect O
. O

For O
binding O
of O
GST B-experiment-tag
proteins O
to O
Cdk2 B-protein
from O
nuclear O
extracts O
, O
purified O
GST O
proteins O
were O
incubated O
with O
50 O
mug O
of O
Jurkat B-cell
cell I-cell
nuclear O
extract O
and O
washed O
three O
times O
with O
IP B-reagent
buffer I-reagent
. O

It O
has O
been O
shown O
that O
AKAP220 B-protein
binds O
to O
PP1 B-protein-family
in O
addition O
to O
PKA B-protein-family
( O
29) O
. O

ACK2 B-protein
binds O
to O
SH3PX1 B-protein
in O
cells O
. O

A O
structural O
superposition O
of O
PP1 B-protein-family
onto O
the O
adenine O
moeity O
of O
ATP B-chemical
bound O
to O
PKA B-protein-family
suggests O
why O
PP1 O
does O
not O
inhibit O
PKA O
( O
Figure O
6B) O
. O

Once O
Ras B-protein-family
is O
bound O
to O
GTP B-chemical
, O
it O
binds O
and O
activates O
these O
RalGEFs B-protein-family
, O
which O
in O
turn O
activate O
Ral B-protein-family
proteins O
. O

The O
areas O
of O
proteolytic O
cleavage O
sites O
that O
become O
accessible O
in O
mu2 O
when O
AP-2 B-protein-complex
binds O
clathrin B-protein-complex
and O
forms O
coats O
are O
indicated O
( O
red) O
. O

The O
phosphorylated O
forms O
of O
β-catenin B-protein-family
bind O
the O
F B-protein-family
box I-protein-family
protein I-protein-family
β-TrCP B-protein
, O
a O
subunit O
of O
the O
SCF-type B-protein-complex
E3 I-protein-complex
ubiquitin I-protein-complex
ligase I-protein-complex
complex I-protein-complex
, O
resulting O
in O
ubiquitination O
of O
β-catenin O
and O
its O
destruction O
by O
the O
proteasome O
Jiang O
and O
Struhl O
1998 O
, O
Winston O
et O
al O
. O
1999 O
, O
Hart O
et O
al O
. O
1999 O
, O
Kitagawa O
et O
al O
. O
1999 O
, O
Polakis O
2001 O
. O

Thus O
, O
binding O
of O
BAD B-protein
and O
PKC B-protein-family
to O
alpha-synuclein B-protein
are O
inversely O
correlated O
. O

This O
protein O
family O
is O
characterized O
by O
a O
J B-protein-domain
domain I-protein-domain
, O
a O
highly O
conserved O
tetrahelical O
domain O
that O
binds O
to O
Hsp70 B-protein-family
chaperones O
and O
activates O
their O
ATPase B-protein-family
activity O
. O

Binding O
of O
soluble O
DSL B-protein-family
proteins O
to O
Notch2 B-protein
on O
the O
cell O
surface O
. O

However O
, O
we O
have O
been O
unable O
to O
demonstrate O
direct O
binding O
of O
purified O
hsp90 B-protein-family
to O
purified O
hsp70 B-protein-family
( O
25) O
, O
and O
when O
the O
hydroxylapatite O
pool O
of O
brain O
cytosol O
is O
incubated O
with O
purified O
hsp90 O
, O
we O
do O
not O
recover O
an O
hsp90 O
. O
hsp70 O
complex O
( O
Fig O
. O
4) O
. O

Daam1 B-protein
binds O
to O
both O
Dsh B-protein-family
and O
RhoA B-protein
, O
and O
mediates O
Wnt-induced -
Dsh-RhoA B-protein-complex
complex O
formation O
. O

Using O
P19 B-cell
cells O
, O
we O
show O
that O
BMP7 B-protein
and O
activin B-protein-complex
bind O
to O
the O
common O
type O
II O
receptors O
, O
ActRII B-protein
and O
IIB B-protein
, O
but O
recruit O
different O
type O
I O
receptors O
into O
the O
ligand-receptor O
complex O
and O
activate O
distinct O
Smad B-process
signaling I-process
pathways I-process
. O

The O
key O
observation O
that O
stimulated O
the O
current O
investigation O
was O
that O
although O
SREBPs B-protein
bind O
to O
both O
types O
of O
sites O
, O
sterol B-chemical
regulation O
in O
all O
promoters O
analyzed O
carefully O
to O
date O
is O
mediated O
through O
SREBP B-protein
binding O
to O
SRE B-DNA
elements I-DNA
and O
not O
the O
classic O
E-box B-DNA
palindrome I-DNA
. O

The O
cytoplasmic O
domain O
of O
cadherin B-protein-family
binds O
to O
beta-catenin B-protein-family
, O
and O
this O
complex O
is O
linked O
to O
the O
actin B-protein-family
cytoskeleton O
by O
alpha-catenin B-protein-family
. O

We O
have O
also O
determined O
that O
the O
carboxyl-terminal O
domain O
of O
Fu B-protein
is O
necessary O
and O
sufficient O
for O
the O
direct O
binding O
of O
Fu O
to O
Cos2 B-protein
. O

We O
found O
that O
the O
GST-SET -
domain -
fusion O
protein O
selectively O
retained O
histones B-protein-family
H3 I-protein-family
and O
H4 B-protein-family
, O
whereas O
binding O
to O
H2A B-protein-family
and O
H2B B-protein-family
was O
significantly O
weaker O
. O

After O
washing O
, O
calmodulin B-protein-family
bound O
to O
fusion O
proteins O
was O
eluted O
and O
resolved O
by O
SDS-PAGE B-assay
. O

One O
reaction O
mixture O
containing O
eIF4A B-protein
but O
no O
eIF4G B-protein
fragment O
indicated O
that O
nonspecific O
binding O
of O
eIF4A O
was O
negligible O
( O
lane O
12) O
. O

Measurement O
of O
the O
Binding O
of O
Annexin B-protein
II I-protein
to O
β2GPI B-protein
by O
Surface O
Plasmon O
Resonance O

The O
studies O
described O
above O
demonstrate O
that O
annexin B-protein
II I-protein
mediates O
the O
binding O
of O
β2GPI B-protein
to O
endothelial O
cells O
but O
do O
not O
address O
the O
issue O
of O
whether O
phospholipid B-chemical
, O
glycosaminoglycans B-chemical
, O
or O
other O
cell O
surface O
proteins O
are O
also O
required O
for O
this O
interaction O
. O

These O
studies O
support O
a O
model O
in O
which O
Sfl1 B-protein
binds O
to O
the O
ERS B-DNA
, O
perhaps O
in O
conjunction O
with O
other O
DNA B-protein-family
-binding I-protein-family
proteins I-protein-family
, O
and O
functions O
to O
repress O
SUC2 B-gene
transcription O
. O

In O
particular O
, O
pairwise O
binding O
of O
CytR B-protein
and O
CRP B-protein
to O
either O
site O
appears O
to O
be O
essentially O
noncooperative O
when O
evaluated O
from O
CRP O
titrations O
. O

This O
most O
likely O
occurs O
through O
the O
interaction O
between O
SLBP B-protein
bound O
to O
the O
pre-mRNA B-RNA
and O
a O
protein O
of O
the O
U7 B-protein-RNA-complex
snRNP I-protein-RNA-complex
or O
another O
factor O
that O
would O
bridge O
SLBP O
and O
U7snRNP B-protein-RNA-complex
. O

In O
Aplysia B-organism
, O
as O
in O
mammals O
, O
the O
regulation O
of O
gene O
transcription O
by O
cAMP B-chemical
is O
mediated O
by O
cAMP B-protein
Responsive I-protein
Element I-protein
( I-protein
CRE I-protein
) I-protein
binding I-protein
protein I-protein
CREB B-protein
. O

CYFIP1 B-protein
( O
or O
p140Sra-1 B-protein
, O
specifically B-protein
Rac1-associated I-protein
protein I-protein
) O
or O
CYFIP2 B-protein
( O
or O
PIR121 B-protein
or O
pop) -
, O
which O
presents O
94 O
. O
5% O
of O
sequence O
similarities O
with O
CYFIP1 O
, O
have O
been O
shown O
to O
be O
specific O
targets O
of O
Rac1 O
, O
binding O
only O
to O
the O
GTP-bound -
form O
of O
Rac1 O
. O

The O
activity O
of O
RalA B-protein
on O
Sec5 B-protein
may O
also O
regulate O
the O
actin B-protein-family
cytoskeleton O
, O
as O
prevention O
of O
Sec5 O
binding O
to O
RalA O
inhibited O
RalA O
from O
inducing O
filopodia B-organelle
formation O
, O
where O
inhibition O
of O
secretion O
with O
BFA B-chemical
had O
no O
effect O
( O
Sugihara O
et O
al O
. O
, O
2002 O
) O
. O

While O
we O
do O
not O
discount O
the O
possibility O
that O
the O
first O
two O
explanations O
may O
be O
valid O
for O
some O
of O
the O
confusion O
in O
the O
literature O
, O
in O
this O
report O
we O
show O
evidence O
that O
Src B-protein
can O
phosphorylate O
the O
EGF-R B-protein
on O
novel O
sites O
in O
vitro O
, O
that O
Src O
and O
P85α B-protein
preferentially O
associate O
with O
the O
EGF-R O
after O
it O
has O
been O
phosphorylated O
by O
Src O
, O
that O
these O
Src-phosphorylated O
sites O
( O
including O
consensus O
binding O
sites O
for O
Src O
and O
P85α O
) O
are O
phosphorylated O
in O
cells O
in O
response O
to O
EGF O
, O
that O
P85α O
and O
Src O
bind O
to O
the O
EGF-R O
in O
these O
cells O
in O
an O
EGF-dependent O
manner O
, O
and O
that O
Csk-inactivated -
Src O
is O
reactivated O
upon O
binding O
to O
the O
Src O
phosphorylated O
EGF-R O
. O

Phosphorylation O
of O
Y1176 B-amino-acid
prevents O
L1 B-protein-family
binding O
to O
AP-2 B-protein-complex
, O
an O
adaptor O
required O
for O
clathrin-mediated -
internalization O
of O
L1 O
. O

Therefore O
, O
the O
cytosol B-organelle
was O
used O
for O
testing O
the O
effects O
of O
GST-Mnbk/ -
Dyrk1A -
supplementation O
on O
the O
binding O
of O
dynamin B-protein-family
to O
GST-Amp(SH3) -
. O

In O
contrast O
, O
while O
binding O
of O
NCS-1 B-protein
to O
calcineurin B-protein-complex
was O
increased O
at O
10 O
muM O
Ca2+ B-chemical
it O
was O
also O
detectable O
at O
0 O
Ca2+ O
. O

Perhaps O
it O
is O
another O
region O
of O
CBP B-protein
, O
not O
the O
KIX B-protein-domain
domain I-protein-domain
, O
which O
is O
bound O
to O
the O
CREB B-protein-complex
complexes I-protein-complex
after O
depolarization O
, O
or O
perhaps O
CBP O
binds O
to O
another O
nearby O
factor O
, O
though O
a O
stimulatory O
role O
for O
such O
CBP O
binding O
remains O
unproven O
. O

( O
D O
) O
Once O
licensing O
is O
complete O
Cdc6 B-protein
is O
removed O
, O
whilst O
ORC B-protein-complex
binds O
less O
tightly O
( O
unshaded O
ORC O
denotes O
weak O
binding O
to O
DNA) -
. O

These O
findings O
suggest O
that O
ATP B-chemical
plays O
a O
critical O
role O
in O
regulating O
ORC B-protein-complex
function O
, O
but O
the O
lack O
of O
direct O
assays O
for O
ATP O
binding O
or O
hydrolysis O
catalyzed O
by O
ORC O
has O
limited O
the O
ability O
to O
study O
this O
aspect O
of O
ORC O
control O
. O

The O
experiments O
of O
Fig O
. O
5 O
were O
performed O
to O
determine O
if O
p50 B-protein
cdc37 I-protein
also O
binds O
directly O
to O
Raf B-protein-family
. O

The O
first O
is O
that O
the O
strength O
of O
the O
tubulin-motor -
interaction O
partly O
overrides O
the O
coiled-coil O
interaction O
within O
the O
kinesin B-protein-family
dimer O
, O
forcing O
the O
heads O
to O
come O
apart O
so O
that O
the O
individual O
kinesin O
molecules O
can O
bind O
to O
different O
tubulin B-protein-complex
heterodimers I-protein-complex
, O
relieving O
the O
constraints O
imposed O
by O
the O
coiled-coil O
necks O
( O
Thormählen O
et O
al O
. O
, O
1998b) O
. O

The O
3′ B-RNA
UTR I-RNA
of O
msl-2 B-gene
contributes O
a O
function O
in O
addition O
to O
SXL B-protein
binding O
( O
Figure O
2E) O
. O

The O
FN B-protein-domain
region O
of O
MSL1 B-protein
that O
binds O
to O
MSL2 B-protein
was O
chosen O
originally O
for O
expression O
in O
flies O
because O
we O
predicted O
, O
using O
the O
method O
of O
Woolfson O
and O
Alber O
( O
1995) O
, O
that O
almost O
half O
of O
FN O
( O
amino O
acids O
96-172 O
) O
would O
form O
a O
two‐stranded O
, O
α‐helical O
, O
coiled‐coil O
structure O
( O
Figure O
11) O
. O

To O
rule O
out O
the O
possibility O
that O
the O
IVT-Hairy -
is O
homodimerizing O
in O
this O
assay O
through O
Hairy O
' O
s O
basic O
helix-loop-helix O
domain O
with O
one O
of O
the O
Hairy O
subunits O
binding O
to O
GST-dCtBP -
and O
the O
other O
binding O
to O
IVT-Gro B-protein
, O
we O
repeated O
the O
assay O
with O
a O
truncated O
form O
of O
IVT-Hairy O
. O

GU O
, O
W O
. O
and O
R O
. O
G O
. O
ROEDER O
, O
1997 O
Activation O
of O
p53 B-protein
sequence-specific O
DNA B-DNA
binding O
by O
acetylation O
of O
the O
P53 O
C-terminal O
domain O
. O

We O
have O
shown O
that O
Axin B-protein-family
directly O
binds O
to O
the O
armadillo B-protein-domain
repeats I-protein-domain
of O
beta-catenin B-protein-family
( O
45 O
, O
51) O
. O

  O
E O
and O
F O
, O
Mg2+ B-chemical
dependence O
of O
the O
22C11 B-reagent
action O
on O
the O
turnover O
number O
of O
GTPase B-protein-family
activity O
( O
E O
) O
or O
GTPγS B-chemical
binding O
activity O
( O
F O
) O
of O
APP695/Go B-protein-complex
vesicles O
. O

A O
point O
mutation O
or O
a O
small O
deletion O
in O
the O
basic O
region O
of O
c-Jun B-protein
renders O
it O
unable O
to O
bind O
to O
the O
AP-1 B-protein-complex
site O
, O
and O
consequently O
inactivates O
the O
transcriptional O
activity O
of O
c-Jun O
and O
its O
ability O
to O
synergize O
with O
Smad3 B-protein
. O

These O
results O
suggest O
that O
l-afadin -
and O
vinculin B-protein
bind O
to O
ponsin B-protein
in O
a O
competitive O
manner O
, O
and O
that O
l-afadin O
, O
ponsin O
, O
and O
vinculin O
hardly O
form O
a O
ternary O
complex O
. O

Since O
removal O
of O
these O
two O
residues O
destroys O
the O
ability O
of O
the O
C-ERMAD B-protein-domain
to O
bind O
the O
N-ERMAD B-protein-domain
( O
18) O
, O
the O
most O
likely O
interpretation O
is O
that O
the O
C-ERMAD O
inhibits O
the O
binding O
of O
EBP50 B-protein
to O
Ez-(1-296) B-experimental-construct
. O

4-Hydroxytamoxifen B-chemical
rapidly O
decreased O
mTAb1 B-reagent
binding O
to O
mTOR B-protein
in O
the O
MER-Akt B-cell
cells I-cell
, O
but O
not O
in O
the O
parental O
NIH B-cell
3T3 I-cell
cells O
( O
Fig O
. O
5 O
A) O
. O

Another O
CBF B-protein
of I-protein
114 I-protein
kDa I-protein
, O
different O
from O
CBF/NF-Y B-protein
, O
was O
also O
reported O
to O
recognize O
the O
CCAAT B-DNA
sequence O
around O
-90 O
( O
13) O
, O
and O
E1A B-protein
and O
p53 B-protein
competitively O
bind O
to O
the O
CBF O
of O
114 O
kDa O
to O
stimulate O
or O
repress O
the O
hsp70 B-DNA
promoter I-DNA
activity O
, O
respectively O
( O
22 O
, O
23) O
. O

The O
binding O
of O
dASF1 B-protein
to O
dCAF-1 B-protein-complex
is O
mediated O
through O
the O
p105 B-protein
subunit O
of O
dCAF-1 O
. O

To O
evaluate O
whether O
both O
CREB B-protein-family
and O
Nfe2l2 B-protein
occupy O
CRE2 B-DNA
and O
the O
overlapping O
NF-E2 B-DNA
binding I-DNA
sites I-DNA
, O
DNase B-protein
I I-protein
footprinting O
was O
performed O
with O
CREB O
and O
Nfe2l2/p18 B-protein-complex
synthesized O
by O
in O
vitro O
transcription O
and O
translation O
. O

Differential O
binding O
of O
talin B-protein-family
and O
filamin B-protein-family
to O
β B-protein-domain
cytoplasmic I-protein-domain
domains I-protein-domain
. O

Furthermore O
, O
beta-catenin B-protein-family
binding O
to O
the O
tumor O
suppressor O
gene O
product O
APC B-protein
( O
adenomatous B-protein
polyposis I-protein
coli I-protein
gene I-protein
( O
45 O
, O
46 O
) O
) O
and O
GSK3beta B-protein
binding O
to O
the O
APC O
. O

Differential O
binding O
of O
apoE B-protein
isoforms O
to O
the O
amyloid O
Abeta B-peptide
peptide O
has O
been O
suggested O
as O
a O
mechanism O
. O

On O
the O
basis O
of O
the O
previous O
findings O
that O
p300 B-protein
binds O
to O
SRC-1 B-protein
through O
this O
region O
, O
we O
speculate O
that O
this O
activation O
occurred O
through O
the O
interaction O
of O
SRC-1 O
with O
p300 O
. O

This O
suggests O
that O
binding O
of O
APC B-protein
and O
GSK3beta B-protein
to O
Axin B-protein-family
promotes O
the O
phosphorylation O
of O
APC O
in O
vivo O
, O
presumably O
by O
GSK3beta O
( O
Rubinfeld O
et O
al O
. O
, O
1996 O
) O
. O

Combination O
of O
EMSA B-assay
studies O
, O
Sp1/Sp3 -
overexpression O
experiments O
in O
Drosophila O
SL-2 B-cell
cells O
, O
and O
systematic O
promoter B-assay
mutagenesis I-assay
identified O
enhanced O
Sp1 O
and O
Sp3 O
binding O
to O
two O
GC-boxes B-DNA
at O
-73/-66 O
and O
-58/-52 O
as O
the O
core O
mechanism O
of O
oxidative O
stress-triggered O
VEGF-A B-protein
transactivation O
. O

Collagen B-peptide
peptides I-peptide
I I-peptide
and O
II B-peptide
effectively O
inhibited O
the O
binding O
of O
both O
alpha1I B-protein-domain
and O
alpha2I B-protein-domain
to O
collagen B-protein-family
in O
a O
dose-dependent O
manner O
( O
Fig O
. O
9) O
. O

EB1 B-protein
binds O
Pin2/TRF1 -
in O
vitro O
and O
in O
vivo O
. O

Binding O
of O
GTP B-chemical
to O
eIF5B B-protein
may O
be O
required O
for O
it O
to O
adopt O
an O
active O
conformation O
. O

These O
results O
suggest O
that O
a O
CREB B-protein
has O
already O
bound O
to O
CRE B-DNA
existing O
in O
the O
cyclin B-protein
D1 I-protein
promoter O
in O
prereplicating O
priming O
of O
hepatocytes O
. O

  O
Also O
, O
like O
E-cadherin B-protein-family
and O
APC B-protein
, O
MUC1 B-protein
binds O
directly O
to O
beta-catenin B-protein
( O
61) O
. O

